Categories Cancer

Cancer Immunotherapeutics Center

Cancer Immunotherapeutics Center Protocol: 19-052Title: A Phase 1/2 First-in-human Study of the Safety and Efficacy of IMC-C103C as a Single Agent and in Combination with Atezolizumab in HLA-A*0201-positive Patients Protocol: 19-063Title: Phase 1/1b Study of the Safety of TTX-030 as a Single Agent and in Combination with Pembrolizumab or Chemotherapy in Patients with Lymphoma or […]

Read More
Categories Cancer

Immunotherapy may work better in stomach cancer when combined with chemotherapy

Immunotherapy may work better in stomach cancer when combined with chemotherapy Washington [US], November 6 (ANI): Immunotherapy for stomach cancer may work better if the therapy is delivered earlier in the course of the disease and in combination with standard chemotherapy, a new study from researchers at Columbia University Vagelos College of Physicians and Surgeons […]

Read More
Categories Multiple Myeloma

Nektar Therapeutics (NKTR) Q3 2020 Earnings Call Transcript

Nektar Therapeutics (NKTR) Q3 2020 Earnings Call Transcript Image source: The Motley Fool. Nektar Therapeutics (NASDAQ:NKTR)Q3 2020 Earnings CallNov 5, 2020, 5:00 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Ladies and gentlemen, thank you for standing by, and welcome to the Nektar Therapeutics Third Quarter 2020 Financial Results. [Operator Instructions] I […]

Read More